Thomas O’Brien
Impact in
- Geriatrics and Gerontology top 1%
- Sirtuins and Resveratrol in Medicine
- Physiology top 2%
Papers in
-
- RNA Research and Splicing 6
- Cell death mechanisms and regulation 6
- Heat shock proteins research 6
- Oncology 18
- PARP inhibition in cancer therapy 11
- Cancer-related Molecular Pathways 5
- Co-authors
- John T. Lis (6 shared papers)Daniel A. Erlanson (4 shared papers)Robert S. McDowell (4 shared papers)Robert Tjian (3 shared papers)S. E. Hardin (1 shared paper)Arno L. Greenleaf (1 shared paper)Joni W. Lam (6 shared papers)Deepak Sampath (13 shared papers)
- Journals
- Cancer Research (6 papers)Molecular and Cellular Biology (4 papers)Neoplasia (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Thomas O’Brien
59 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 131
- Geriatrics and Gerontology 351
- Physiology 180
- Molecular Biology 2.7k
- Oncology 743
- Aging 44
Countries citing papers authored by Thomas O’Brien
This map shows the geographic impact of Thomas O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas O’Brien more than expected).
Fields of papers citing papers by Thomas O’Brien
This network shows the impact of papers produced by Thomas O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas O’Brien. The network helps show where Thomas O’Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 493 | |
| 2 | 1994 | 295 | |
| 3 | 2015 | 199 | |
| 4 | 2004 | 188 | |
| 5 | 2018 | 186 | |
| 6 | 2011 | 170 | |
| 7 | 2003 | 155 | |
| 8 | 1993 | 136 | |
| 9 | 1991 | 109 | |
| 10 | 2009 | 106 | |
| 11 | 2007 | 98 | |
| 12 | 1995 | 91 | |
| 13 | 2002 | 83 | |
| 14 | 1995 | 78 | |
| 15 | 2016 | 70 | |
| 16 | 2013 | 64 | |
| 17 | 2014 | 64 | |
| 18 | 2013 | 59 | |
| 19 | 2014 | 58 | |
| 20 | 2000 | 56 |
About Thomas O’Brien
Thomas O’Brien is a scholar working on Molecular Biology, Oncology, Geriatrics and Gerontology, Epidemiology and Physiology, having authored 62 papers that have together received 3.6k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (12 papers), PARP inhibition in cancer therapy (11 papers), Autophagy in Disease and Therapy (7 papers), RNA Research and Splicing (6 papers), Calcium signaling and nucleotide metabolism (6 papers), Cell death mechanisms and regulation (6 papers), Heat shock proteins research (6 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Geriatrics and Gerontology (351 citations), Physiology (180 citations), Molecular Biology (2.7k citations), Oncology (743 citations) and Aging (44 citations). Thomas O’Brien has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include John T. Lis, Daniel A. Erlanson, Robert S. McDowell, Robert Tjian, S. E. Hardin, Arno L. Greenleaf, Joni W. Lam, Deepak Sampath, Adam G. Eldridge and Peter S. Dragovich. Their work appears in journals such as Cancer Research, Molecular and Cellular Biology, Neoplasia, Bioorganic & Medicinal Chemistry Letters and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.